Delivery Order SPE2DB22D2206-SPE2DB25FJP04
Award Date 8/21/25
Potential Completion Date 8/22/25
Potential Value $8.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,533.49 to AmerisourceBergen Drug Corp for Xeljanz XR 11 mg tablets (30-count units) on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed price delivery order was competitively awarded without any set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction within DLA's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xeljanz XR 11 mg tablets (30-count units) valued at $8,107.66 under a firm fixed-price contract type. The award was made on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing critical medical supplies to federal healthcare...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside order carries a ceiling value of $11,698.84 with firm fixed pricing and is scheduled for completion by September 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor supporting federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $3,198.50, was competitively awarded without set-aside designation and is scheduled for completion by August 22, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $8,025.05 to AmerisourceBergen Drug Corp for the supply of Xeljanz XR 11 mg tablets (30-count units) on September 8, 2025, with completion scheduled for September 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a small-value transaction under a larger federal...
- The Defense Logistics Agency awarded a delivery order valued at $10,862.72 to AmerisourceBergen Drug Corp for the supply of Xeljanz XR 11 mg tablets (30-count units) with a firm fixed-price structure. This non-set-aside competitive award was issued on May 30, 2025, with an ultimate completion date of June 2, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $73,540.08 to AmerisourceBergen Drug Corp for the supply of Xeljanz XR 11 mg tablets (30-count units) with a completion deadline of April 30, 2025. This competitively awarded, firm fixed-price contract was issued on April 29, 2025, with no set-aside designation. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $46,224.65 for Xeljanz XR 11 mg tablets (30-count unit of use packaging) on April 24, 2025, with completion scheduled for April 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's ongoing supply of pharmaceutical products to federal medical procurement needs. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Xeljanz XR 11 mg tablets in a quantity of 30-tablet units, with a contract ceiling value of $13,740.06. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The contract is scheduled for ultimate completion on September 12, 2025, and will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $5,712.80 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Xeljanz XR 11 mg tablets (30-count units). This is a firm fixed price delivery order with no set-aside designation, requiring completion by June 20, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and...